Mov Disord. 2022 Jun 20. doi: 10.1002/mds.29123. Online ahead of print.ABSTRACTBACKGROUND: Cognitive impairment is common in neurological presentations of Wilson's disease (WD). Various domains can be affected, and subclinical deficits have been reported in patients with hepatic presentations. Associations with imaging abnormalities have not been systematically tested.OBJECTIVE: The aim was to determine the neuroanatomical basis for cognitive deficits in WD.METHODS: ... read more
Source: PubMedPublished on 2022-06-20By Samuel Shribman
Related Articles:
- The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s. It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
- The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
- The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
- 2019: Year in review December 31, 2019 In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2019. Month-by-month we will briefly discuss some of the major pieces of research/announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies to any researchers who…
- Shining a light on Parkinson’s November 7, 2019 NOTE: The information in today’s post should not be considered an endorsement of PhotoPharmics or the treatment they are proposing. The author of this blog has had no communication with the company. The information in this post is provided because the author has been asked by readers to discuss it. In October 2018, at the annual International Movement Disorders…
- [Video] Poetry as Medicine Cafe – Using Poetry to Live Well with Parkinson’s February 25, 2021 Last summer, a group of Davis Phinney Foundation Ambassadors came together for a Poetry as Medicine workshop with Wayne Gilbert. What began as a one-hour session turned into a monthly poetry jam that has resulted in far more than words on a page. At our first ever Poetry as Medicine Cafe, these poets shared with us some pieces of their collection of work. Watch…
- Journey With Parkinson’s: (Part 2) A Different Side of Life November 2, 2020 “Yesterday is but today’s memory, and tomorrow is today’s dream.” Khalil Gibran “Time is free, but it’s priceless. You can’t own it, but you can use it. You can’t keep it, but you can spend it. Once you’ve lost it you can never get it back.” Harvey Mackay Introduction: I am a scientist, trained as a protein chemist with expertise…
- Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease June 20, 2022 Mov Disord. 2022 Jun 20. doi: 10.1002/mds.29123. Online ahead of print.ABSTRACTBACKGROUND: Cognitive impairment is common in neurological presentations of Wilson's disease (WD). Various domains can be affected, and subclinical deficits have been reported in patients with hepatic presentations. Associations with imaging abnormalities have not been systematically tested.OBJECTIVE: The aim was to determine the neuroanatomical basis for cognitive deficits in WD.METHODS:…
- Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease June 20, 2022 Mov Disord. 2022 Jun 20. doi: 10.1002/mds.29123. Online ahead of print.ABSTRACTBACKGROUND: Cognitive impairment is common in neurological presentations of Wilson's disease (WD). Various domains can be affected, and subclinical deficits have been reported in patients with hepatic presentations. Associations with imaging abnormalities have not been systematically tested.OBJECTIVE: The aim was to determine the neuroanatomical basis for cognitive deficits in WD.METHODS:…
- Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease June 20, 2022 Mov Disord. 2022 Jun 20. doi: 10.1002/mds.29123. Online ahead of print.ABSTRACTBACKGROUND: Cognitive impairment is common in neurological presentations of Wilson's disease (WD). Various domains can be affected, and subclinical deficits have been reported in patients with hepatic presentations. Associations with imaging abnormalities have not been systematically tested.OBJECTIVE: The aim was to determine the neuroanatomical basis for cognitive deficits in WD.METHODS:…
- Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease June 20, 2022 Mov Disord. 2022 Jun 20. doi: 10.1002/mds.29123. Online ahead of print.ABSTRACTBACKGROUND: Cognitive impairment is common in neurological presentations of Wilson's disease (WD). Various domains can be affected, and subclinical deficits have been reported in patients with hepatic presentations. Associations with imaging abnormalities have not been systematically tested.OBJECTIVE: The aim was to determine the neuroanatomical basis for cognitive deficits in WD.METHODS:…
- Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease June 20, 2022 Mov Disord. 2022 Jun 20. doi: 10.1002/mds.29123. Online ahead of print.ABSTRACTBACKGROUND: Cognitive impairment is common in neurological presentations of Wilson's disease (WD). Various domains can be affected, and subclinical deficits have been reported in patients with hepatic presentations. Associations with imaging abnormalities have not been systematically tested.OBJECTIVE: The aim was to determine the neuroanatomical basis for cognitive deficits in WD.METHODS:…
- 2020: Year in Review January 1, 2021 # # # # In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2020. Month-by-month we will briefly discuss some of the major pieces of research/ announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies…
- Monthly Research Review – May 2021 May 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during May 2021. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
- Speech, Voice & Parkinson’s Q&A with John Dean January 28, 2021 We recently hosted a webinar with speech-language pathologist John Dean. You can get access to the recording here. We received so many questions during the session that we weren’t able to answer them all; so, John was kind enough to do some written Q&A for us. “When is a good time to start speech therapy?” It’s much better to maintain…
- Repurposing bumetanide for Alzheimer’s October 15, 2021 # # # # Bumetanide (Bumex) is a diuretic drug (a medication that removes water, by increasing the production of urine). It is used to treat swelling caused by heart failure or liver or kidney disease. It is a widely used drug that has been well characterised in clinical use. Recently researchers conducted a screening study to identify clinically available…
- The “What would I do” post? Part 2 January 22, 2022 # # # # I am very regularly asked “what would you do if you were diagnosed with Parkinson’s tomorrow?” As a research scientist I don’t really feel comfortable answering it, but I can see how it is a fair question. I have previously attempted to address it (Click here to read that post), and I point folks who do…
- Milestones in Parkinson’s Disease Research and Discovery April 11, 2017 “The real voyage of discovery consists not in seeking new landscapes, but in having new eyes.” Marcel Proust “The process of scientific discovery is, in effect, a continual flight from wonder.” Albert Einstein Preface: Happy birthday to James Parkinson (neurologist, geologist, scientist, activist), born April 11, 1755 and died December 21, 1824. World Parkinson’s Day April 11, 2017. Introduction to…
- Monthly Research Review: January 2022 January 31, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during January 2022. The post is divided into 10 parts based on the type of research: Top 6 pieces of Parkinson’s news Articles of general interest Basic biology…
- Telemedicine study funded by the Davis Phinney Foundation leads to breakthroughs for people with Parkinson’s March 9, 2021 In 2012, long before healthcare had to adapt to the COVID-19 pandemic, the Davis Phinney Foundation funded one of the first studies on telemedicine and its impacts on people’s health with Parkinson’s. Nearly nine years later, its findings are more relevant than ever. The investigation became a powerful springboard for future research on telemedicine and Parkinson’s. The outcomes of the many…
- Be one with Vitamin B1 April 13, 2022 # # # # BEFORE WE START: There are some topics that I am reluctant to address on this website, because there are folks within the community who have extremely vested interests in them. Thiamine (or Vitamin B1) is one of those topics. Some members of the Parkinson’s community have indicated to me that high doses of this…
- Breathtaking research April 24, 2022 # # # # Breathing is one of those many aspects of life that we all take completely for granted for the vast majority of our time on planet Earth. It represents not only a magnificent means of providing our bodies with oxygen, but also disposing of waste. Recently researchers have attempted to see if there are any components in…